Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survivalEzgi Ozyerli‐Goknar, Tugba Bagcı-Önder, Sonia H.Y. Kung et al.|Cell Communication and Signaling|2023Cited by 12
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancerOzlem Yedier-Bayram, Tugba Bagcı-Önder, Ahmet Cingöz et al.|Experimental & Molecular Medicine|2025Cited by 4
Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survivalEzgi Ozyerli‐Goknar, Tugba Bagcı-Önder, Ezgi Yağmur Kala et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancerOzlem Yedier-Bayram, Tugba Bagcı-Önder, Ahmet Cingöz et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0
Abstract 4404: BRPF1 inhibition restores chemosensitivity in triple negative breast cancer via ribosomal pathway modulationOzlem Yedier-Bayram, Tugba Bagcı-Önder, Ahmet Cingöz et al.|Cancer Research|2025Cited by 0